It has been recently proposed that IL-17A induces protein and mRNA regulation of C3, and limiting complement activation by neutralising IL-17A is a potential mechanism for ameliorating pulmonary fibrosis (45). The gene discussed is C3; the disease is pulmonary fibrosis.